Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000332737 | SCV000345916 | uncertain significance | not provided | 2016-09-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001039823 | SCV001203371 | uncertain significance | Combined immunodeficiency due to STK4 deficiency | 2021-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002519354 | SCV003581124 | uncertain significance | Inborn genetic diseases | 2021-09-22 | criteria provided, single submitter | clinical testing | The c.1004G>A (p.G335D) alteration is located in exon 9 (coding exon 9) of the STK4 gene. This alteration results from a G to A substitution at nucleotide position 1004, causing the glycine (G) at amino acid position 335 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |